Literature DB >> 15143467

Body-composition changes in the simian immunodeficiency virus-infected juvenile rhesus macaque.

Lisa M Freeman1, Keith G Mansfield, Barry Goldin, Margo Woods, Lisa Gualtieri, Wenjun Li, Sarah Bussell, Andrew Lackner, Sherwood L Gorbach.   

Abstract

BACKGROUND: Body-composition changes are common in individuals infected with human immunodeficiency virus. The purpose of the present study was to measure, as a model of wasting in acquired immunodeficiency syndrome (AIDS), longitudinal body-composition changes in macaques infected with simian immunodeficiency virus (SIV).
METHODS: Twelve juvenile macaques were inoculated with SIVmac239. Immunologic, virologic, somatometric, and dual-energy x-ray-absorptiometry measurements were performed prospectively every 4 weeks for 72 weeks and were compared to measurements taken from 8 uninfected control macaques.
RESULTS: During the first 4 weeks, body-fat percentage decreased in the SIV-infected macaques while lean-tissue percentage increased; during weeks 4-72, these macaques lost a greater percentage of total fat tissue but had more subcutaneous-fat deposition than did the uninfected control macaques. Just prior to death, the SIV-infected macaques that died (n=7) had a greater loss in body-mass index, abdominal fat, fat tissue, and lean tissue, compared with that in SIV-infected macaques that survived (n=5).
CONCLUSIONS: Body-composition changes in SIV-infected juvenile macaques exhibit 3 phases: during acute infection, loss of body weight from fat tissue; a compensation period during which macaques grow, but at a reduced rate; and a terminal phase, during which tissue is lost from all body compartments. The SIV-infected juvenile macaque provides a useful model for the investigation of wasting in AIDS, particularly for pediatric AIDS wasting.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143467     DOI: 10.1086/386290

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.

Authors:  Samantha L Sampson; Keith G Mansfield; Angela Carville; D Mitchell Magee; Teresa Quitugua; Elizabeth W Howerth; Barry R Bloom; Mary K Hondalus
Journal:  Vaccine       Date:  2011-05-05       Impact factor: 3.641

2.  The effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques.

Authors:  Karyn E O'Connell; Wen Guo; Carlo Serra; Matthew Beck; Lynn Wachtman; Amber Hoggatt; Dongling Xia; Chris Pearson; Heather Knight; Micheal O'Connell; Andrew D Miller; Susan V Westmoreland; Shalender Bhasin
Journal:  FASEB J       Date:  2014-12-02       Impact factor: 5.191

3.  A recombinant attenuated Mycobacterium tuberculosis vaccine strain is safe in immunosuppressed simian immunodeficiency virus-infected infant macaques.

Authors:  Kara Jensen; Uma Devi K Ranganathan; Koen K A Van Rompay; Don R Canfield; Imran Khan; Resmi Ravindran; Paul A Luciw; William R Jacobs; Glenn Fennelly; Michelle H Larsen; Kristina Abel
Journal:  Clin Vaccine Immunol       Date:  2012-06-13

4.  Chronic Exposure to HIV-Derived Protein Tat Impairs Endothelial Function via Indirect Alteration in Fat Mass and Nox1-Mediated Mechanisms in Mice.

Authors:  Laszlo Kovacs; Thiago Bruder-Nascimento; Lindsey Greene; Simone Kennard; Eric J Belin de Chantemèle
Journal:  Int J Mol Sci       Date:  2021-10-12       Impact factor: 5.923

5.  Pathological manifestations of feline immunodeficiency virus (FIV) infection in wild African lions.

Authors:  Melody E Roelke; Meredith A Brown; Jennifer L Troyer; Hanlie Winterbach; Christiaan Winterbach; Graham Hemson; Dahlem Smith; Randall C Johnson; Jill Pecon-Slattery; Alfred L Roca; Kathleen A Alexander; Lin Klein; Paolo Martelli; Karthiyani Krishnasamy; Stephen J O'Brien
Journal:  Virology       Date:  2009-05-22       Impact factor: 3.616

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.